Results

Willkie Farr & Gallagher LLP

07/30/2024 | News release | Distributed by Public on 07/30/2024 14:46

Willkie Advises Goldman Sachs Alternatives on €120 Million Series B Investment in osapiens

Willkie Advises Goldman Sachs Alternatives on €120 Million Series B Investment in osapiens

News

share

July 30, 2024

Willkie recently advised Goldman Sachs Alternatives on its €120 million Series B investment in osapiens, a leading ESG platform and provider of compliance and sustainability reporting solutions.

On July 29, osapiens announced on the completion of a $120 million Series B financing round led by Growth Equity at Goldman Sachs Alternatives. Based in Germany, osapiens is a leading provider of ESG software solutions and works with an international team of more than 300 employees for more than 1,300 customers worldwide.

Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $450 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, hedge funds and sustainability.

The Willkie team was led by partner Miriam Steets and included partner Jared Fertman and associates Joe Laurel and Denise Kammerer.
Miriam Steets PartnerPrivate Equity
Munich [email protected] +49 89 20304 7509
Jared N. Fertman PartnerCorporate & Financial Services
New York [email protected] +1 212 728 8670
Joe Laurel AssociateCorporate & Financial Services
Houston [email protected] +1 713 510 1756
Denise Kammerer AssociatePrivate Equity
Frankfurt [email protected] +49 69 7930 2142